News Details

( As on 13/01/2022 14:10)

Fabino Life Sciences Ltd. debuts with 6.80% premium at Rs 38.45

Fabino Life Sciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 38.45 on the Bombay Stock Exchange, a 6.80 per cent premium to its issue price of Rs 36.00.

The company, which raised 0.09 Cr from initial public offering, was subscribed 0 times, receiving bids for 0 lakhs shares against the total issue size of 9.00 lakhs shares.

The company, listed under MT Group Securities post its IPO, opened for subscription from Dec 31 to Jan 05.

Following a strong opening, the scrip touched an intraday high of Rs [BSEHighPrice] and a low of Rs [NSEHighPrice], before closing the session [UpDown] by [ChangePer] per cent to its listing price at Rs [ClosingPriceBSE] on the BSE.

The company anticipates using the proceeds of the issue for Part Repayment of Loans Funding Working capital requirements General Corporate Purpose.

Aryaman Financial Services Ltd. as lead managers & Bigshare Services Pvt. Ltd. is the registrar, to the issue.

Meanwhile, the broader benchmark BSE Sensex closed trade at 61,150.04, up 533.15 points, or 0.87 per cent.